Thirty-five-year-old woman with signet ring cell gastric carcinoma secondary to the chernobyl nuclear accident: A case report

Case Reports in Oncology

Volumn 6, Issue 1, 2013, Pages 158-162

  Mayhall, Kim ^a   Ghayouri, Masoumeh ^b   Henry, Katherine ^c   Margin, Veronica ^a   Copolla, Domeinico ^b   Shackelford, Rodney ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Delta Pathology Gretna   (United States)

Author keywords

Chernobyl; Fallout; Malignancy; Signet ring cell gastric carcinoma

Indexed keywords

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; CHERNOBYL ACCIDENT; CHOLECYSTECTOMY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HISTOLOGY; HUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOACTIVE WASTE; SIGNET RING CARCINOMA; STOMACH BIOPSY; STOMACH CARCINOMA; UPPER ABDOMINAL PAIN;

EID: 84877992734     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000350464     Document Type: Article

References (14)

1. Williams D: Radiation carcinogenesis: lessons from Chernobyl. Oncogene 2008;27(suppl 2):S9-S18.
2. Moysich KB, Menezes RJ, Michalek AM: Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review. Lancet Oncol 2002;3:269-279.
3. Shchepotin IB, Valetsky VL, Chorny VA, Shabahang M, Nauta RJ, Buras RR, Evans SR: Carcinoma of the stomach following the Chernobyl nuclear accident. Eur J Cancer 1997;33:1413-1418.
4. Chu PG, Weiss LM: Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol 2004;121:884-892.
5. Zhao ZS, Li L, Wang HJ, Wang YY: Expression and prognostic significance of CEACAM6, ITGB1, and CYR61 in peripheral blood of patients with gastric cancer. J Surg Oncol 2011;104:525-529.
6. Yonezawa S, Kitajima S, Higashi M, Osako M, Horinouchi M, Yokoyama S, Kitamoto S, Yamada N, Tamura Y, Shimizu T, Tabata M, Goto M: A novel anti-MUC1 antibody against the MUC1 cytoplasmic tail domain: use in sensitive identification of poorly differentiated cells in adenocarcinoma of the stomach. Gastric Cancer 2012;15:370-381.
7. Long HL, Che XM, Bi TQ, Li HJ, Liu JS, Li DW: The expression of nicotinamide phosphoribosyl transferase and vascular endothelial growth factor-A in gastric carcinoma and their clinical significance. Zhonghua Wai Ke Za Zhi 2012;50:839-842.
8. Garten A, Petzold S, Körner A, Imai S, Kiess W: Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol Metab 2009;20:130-138.
9. Taghavi S, Jayarajan SN, Davey A, Willis AI: Prognostic significance of signet ring gastric cancer. J Clin Oncol 2012;30:3493-3498.
10. Kim JP, Kim SC, Yang HK: Prognostic significance of signet ring cell carcinoma of the stomach. Surg Oncol 1994;3:221-227.
11. Watanabe H, Ogundigie PO, Takahashi T, Ishimoto T, Ito A: Induction of signet ring cell carcinomas in Xirradiated hypocatalasemic mice (C3H/Cbs). Jpn J Cancer Res 1991;82:1175-1177.
12. Asano N, Iijima K, Terai S, Uno K, Endo H, Koike T, Iwai W, Iwabuchi T, Hatta W, Abe Y, Imatani A, Shimosegawa T: Signet ring cell gastric cancer occurring after radiation therapy for Helicobacter pyloriuninfected mucosa-associated lymphoid tissue lymphoma. Case Rep Gastroenterol 2011;5:325-329.
13. Ito C, Kato M, Yamamoto T, Ota N, Okuhara T, Mabuchi K, Otake M, Munaka M: Study of stomach cancer in atomic bomb survivors. Report 1. Histological findings and prognosis. J Radiat Res 1989;30:164-175.
14. http://apps.who.int/iris/bitstream/10665/78218/1/9789241505130-eng.pdf